Stock Track | MedBot-B Soars 5.16% Intraday on Strong FY2025 Results Showing Revenue Doubling and Loss Narrowing

Stock Track

Mar 27

MEDBOT-B (02252) soared 5.16% during intraday trading on Friday, following the release of its audited financial results for the year ended December 31, 2025.

The company reported a 114.20% year-on-year surge in revenue to RMB 551.07 million, driven by the rapid commercialization of its core laparoscopic robot "Toumai." Overseas sales skyrocketed to more than five times the 2024 level, accounting for 73% of total revenue. The gross profit jumped 209.20% to RMB 266.62 million, with the gross margin expanding to 48% from 34% the previous year.

Furthermore, the net loss narrowed significantly by 60.70% to RMB 254.12 million, while the adjusted net loss fell 65.80%. The company also reported a sharp reduction in free cash outflow and achieved positive free cash flow in the second half of 2025. These robust financial metrics, alongside operational progress including growing global orders for its robotic systems, fueled positive investor sentiment during the session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1104079237"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1104079237\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1104079237?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-27 09:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1104079237","market":"sg","top_or_hot":-1,"title":"Stock Track | MedBot-B Soars 5.16% Intraday on Strong FY2025 Results Showing Revenue Doubling and Loss Narrowing","media":"Stock Track","content":"<p>MEDBOT-B (02252) soared 5.16% during intraday trading on Friday, following the release of its audited financial results for the year ended December 31, 2025.</p><p>The company reported a 114.20% year-on-year surge in revenue to RMB 551.07 million, driven by the rapid commercialization of its core laparoscopic robot \"Toumai.\" Overseas sales skyrocketed to more than five times the 2024 level, accounting for 73% of total revenue. The gross profit jumped 209.20% to RMB 266.62 million, with the gross margin expanding to 48% from 34% the previous year.</p><p>Furthermore, the net loss narrowed significantly by 60.70% to RMB 254.12 million, while the adjusted net loss fell 65.80%. The company also reported a sharp reduction in free cash outflow and achieved positive free cash flow in the second half of 2025. These robust financial metrics, alongside operational progress including growing global orders for its robotic systems, fueled positive investor sentiment during the session.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | MedBot-B Soars 5.16% Intraday on Strong FY2025 Results Showing Revenue Doubling and Loss Narrowing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | MedBot-B Soars 5.16% Intraday on Strong FY2025 Results Showing Revenue Doubling and Loss Narrowing\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-03-27 09:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>MEDBOT-B (02252) soared 5.16% during intraday trading on Friday, following the release of its audited financial results for the year ended December 31, 2025.</p><p>The company reported a 114.20% year-on-year surge in revenue to RMB 551.07 million, driven by the rapid commercialization of its core laparoscopic robot \"Toumai.\" Overseas sales skyrocketed to more than five times the 2024 level, accounting for 73% of total revenue. The gross profit jumped 209.20% to RMB 266.62 million, with the gross margin expanding to 48% from 34% the previous year.</p><p>Furthermore, the net loss narrowed significantly by 60.70% to RMB 254.12 million, while the adjusted net loss fell 65.80%. The company also reported a sharp reduction in free cash outflow and achieved positive free cash flow in the second half of 2025. These robust financial metrics, alongside operational progress including growing global orders for its robotic systems, fueled positive investor sentiment during the session.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02252","symbol_name":"微创机器人-B","start_time":0,"source_url":"","article_id":"1104079237","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1104079237","pubTimestamp":1774575958,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"MEDBOT-B (02252) soared 5.16% during intraday trading on Friday, following the release of its audited financial results for the year ended December 31, 2025.The company reported a 114.20%...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02252":"微创机器人-B"},"translate_title":"个股追踪|MedBot-B盘中飙升5.16%，2025财年业绩强劲，收入翻倍，亏损收窄","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02252":1},"content_text":"MEDBOT-B (02252) soared 5.16% during intraday trading on Friday, following the release of its audited financial results for the year ended December 31, 2025.The company reported a 114.20% year-on-year surge in revenue to RMB 551.07 million, driven by the rapid commercialization of its core laparoscopic robot \"Toumai.\" Overseas sales skyrocketed to more than five times the 2024 level, accounting for 73% of total revenue. The gross profit jumped 209.20% to RMB 266.62 million, with the gross margin expanding to 48% from 34% the previous year.Furthermore, the net loss narrowed significantly by 60.70% to RMB 254.12 million, while the adjusted net loss fell 65.80%. The company also reported a sharp reduction in free cash outflow and achieved positive free cash flow in the second half of 2025. These robust financial metrics, alongside operational progress including growing global orders for its robotic systems, fueled positive investor sentiment during the session.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}